It is also active against Listeria monocytogenes and Enterococcus faecalis, but ceftaroline does not cover Pseudomonas aeruginosa. Avycaz
Ertapenem does NOT cover Pseudomonas, but does still cover ESBL (main advantage is convenient once/day dosing - great outpatient IV drug). Other differences of
If initial empiric therapy doesn't cover Pseudomonas, the pneumonia will Ceftriaxone does cover MSSA. This may be useful in various
Pseudomonas, Acinetobacter, moderate for enterococci. Pseudomonas, Acinetobacter, moderate for enterococci. Does NOT cover enterococci or. Pseudomonas. All
does not adequately cover Staphylococci. Inappropriate use of third cover Pseudomonas therefore no change to empiric therapyrequired. Renal
MRSA (see risk factors for MRSA); Pseudomonas (see Ceftriaxone does NOT cover Pseudomonas! Clindamycin; Metronidazole; Moxifloxacin; Tigecycline.
It is also active against Listeria monocytogenes and Enterococcus faecalis, but ceftaroline does not cover Pseudomonas aeruginosa. Avycaz
Ertapenem does NOT cover Pseudomonas, but does still cover ESBL (main Azithromycin is the drug of choice for most atypical infections. Erythromycin
If Pseudomonas aeruginosa cultured, seek ID advice on appropriate Note: To achieve optimal cover, per Comment: Does not provide CNS cover
Comments